The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 12, 2022
Filed:
May. 18, 2018
Applicant:
Tatsuo Hoshino, Kanagawa, JP;
Inventors:
Tatsuo Hoshino, Kanagawa, JP;
Shinji Kagaya, Kanagawa, JP;
Nobuo Shimma, Kanagawa, JP;
Tsutomu Kawaguchi, Saitama, JP;
Assignee:
Other;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/15 (2006.01); A61K 31/155 (2006.01); A61K 31/5375 (2006.01); A61K 31/495 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61K 31/055 (2006.01); A61K 31/122 (2006.01); A61K 31/215 (2006.01); A61K 31/337 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5375 (2013.01); A61K 31/055 (2013.01); A61K 31/122 (2013.01); A61K 31/15 (2013.01); A61K 31/215 (2013.01); A61K 31/337 (2013.01); A61K 31/495 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01);
Abstract
An object of the present invention is to provide a measure for treating or preventing a disease or condition that involves AMPK dysregulation, particularly a cancer. The present invention provides a combination therapy using a compound presented by formula (I), a pharmaceutically acceptable salt or a solvate thereof with an immune checkpoint inhibitor.